BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 20087644)

  • 21. Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers.
    Tsukasaki K; Miller CW; Kubota T; Takeuchi S; Fujimoto T; Ikeda S; Tomonaga M; Koeffler HP
    Cancer Res; 2001 May; 61(9):3770-4. PubMed ID: 11325850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Childhood social environment and risk of non-Hodgkin lymphoma in adults.
    Smedby KE; Hjalgrim H; Chang ET; Rostgaard K; Glimelius B; Adami HO; Melbye M
    Cancer Res; 2007 Nov; 67(22):11074-82. PubMed ID: 18006854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity and risk of non-Hodgkin lymphoma (United States).
    Chiu BC; Soni L; Gapstur SM; Fought AJ; Evens AM; Weisenburger DD
    Cancer Causes Control; 2007 Aug; 18(6):677-85. PubMed ID: 17484069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: a population-based case-control study.
    Chiu BC; Kolar C; Gapstur SM; Lawson T; Anderson JR; Weisenburger DD
    Br J Haematol; 2005 Mar; 128(5):610-5. PubMed ID: 15725081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
    Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcón GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
    Am J Epidemiol; 2015 Mar; 181(6):406-21. PubMed ID: 25713336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.
    Seidemann K; Zimmermann M; Book M; Meyer U; Burkhardt B; Welte K; Reiter A; Stanulla M
    J Clin Oncol; 2005 Nov; 23(33):8414-21. PubMed ID: 16293872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk.
    Nieters A; Beckmann L; Deeg E; Becker N
    Genes Immun; 2006 Dec; 7(8):615-24. PubMed ID: 16971956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women.
    Morton LM; Engels EA; Holford TR; Leaderer B; Zhang Y; Zahm SH; Boyle P; Zhang B; Flynn S; Tallini G; Owens PH; Zheng T
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):425-30. PubMed ID: 15006919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Birth order, atopy, and risk of non-Hodgkin lymphoma.
    Grulich AE; Vajdic CM; Kaldor JM; Hughes AM; Kricker A; Fritschi L; Turner JJ; Milliken S; Benke G; Armstrong BK
    J Natl Cancer Inst; 2005 Apr; 97(8):587-94. PubMed ID: 15840881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
    Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Family history of hematopoietic and non-hematopoietic malignancies and risk of non-Hodgkin lymphoma.
    Zhang Y; Wang R; Holford TR; Leaderer B; Zahm SH; Boyle P; Zhu Y; Qin Q; Zheng T
    Cancer Causes Control; 2007 May; 18(4):351-9. PubMed ID: 17206533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sun exposure and non-Hodgkin lymphoma: a population-based, case-control study.
    Soni LK; Hou L; Gapstur SM; Evens AM; Weisenburger DD; Chiu BC
    Eur J Cancer; 2007 Nov; 43(16):2388-95. PubMed ID: 17686627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.
    Morton LM; Purdue MP; Zheng T; Wang SS; Armstrong B; Zhang Y; Menashe I; Chatterjee N; Davis S; Lan Q; Vajdic CM; Severson RK; Holford TR; Kricker A; Cerhan JR; Leaderer B; Grulich A; Yeager M; Cozen W; Hoar Zahm S; Chanock SJ; Rothman N; Hartge P
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1259-70. PubMed ID: 19336552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations.
    Hosgood HD; Au WY; Kim HN; Liu J; Hu W; Tse J; Song B; Wong KF; Lee JJ; Chanock SJ; Siu LP; Purdue MP; Shin MH; Yu J; Liang R; Kim HJ; Rothman N; Lan Q
    Int J Hematol; 2013 Jun; 97(6):793-9. PubMed ID: 23640160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D receptor genotypes, ultraviolet radiation exposure, and risk of non-Hodgkin lymphoma.
    Smedby KE; Eloranta S; Duvefelt K; Melbye M; Humphreys K; Hjalgrim H; Chang ET
    Am J Epidemiol; 2011 Jan; 173(1):48-54. PubMed ID: 21076051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between genetic variants in immunoregulatory genes and risk of non-Hodgkin lymphoma in a Chinese population.
    Ye X; Zhao K; Wu C; Hu P; Fu H
    Oncotarget; 2017 Feb; 8(6):10450-10457. PubMed ID: 28060727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No association between the TP53 codon 72 polymorphism and risk or prognosis of Hodgkin and non-Hodgkin lymphoma.
    Havranek O; Spacek M; Hubacek P; Mocikova H; Benesova K; Soucek P; Trneny M; Kleibl Z
    Leuk Res; 2011 Aug; 35(8):1117-9. PubMed ID: 21546086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokines in serum in relation to future non-Hodgkin lymphoma risk: evidence for associations by histologic subtype.
    Edlefsen KL; Martínez-Maza O; Madeleine MM; Magpantay L; Mirick DK; Kopecky KJ; LaCroix AZ; De Roos AJ
    Int J Cancer; 2014 Aug; 135(4):913-22. PubMed ID: 24488825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.
    Wang SS; Davis S; Cerhan JR; Hartge P; Severson RK; Cozen W; Lan Q; Welch R; Chanock SJ; Rothman N
    Carcinogenesis; 2006 Sep; 27(9):1828-34. PubMed ID: 16543247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma cytokines and future risk of non-Hodgkin lymphoma (NHL): a case-control study nested in the Italian European Prospective Investigation into Cancer and Nutrition.
    Saberi Hosnijeh F; Krop EJ; Scoccianti C; Krogh V; Palli D; Panico S; Tumino R; Sacredote C; Nawroly N; Portengen L; Linseisen J; Vineis P; Vermeulen R
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1577-84. PubMed ID: 20501772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.